ライフサイエンスコーパス: radiolabeling

1 ]sulfonyl fluorides as synthons for indirect radiolabeling.

2 n inverse stoichiometries used for efficient radiolabeling.

3 3) that served as an immediate precursor to radiolabeling.

4 rometry, tryptic peptide analysis, and (32)P radiolabeling.

5 abeled leukocytes was evaluated at 3 h after radiolabeling.

6 phatidylinositide (Ptide) metabolism without radiolabeling.

7 ble to rapidly study ADME/PK in vivo without radiolabeling.

8 he substrate variability caused by continual radiolabeling.

9 stability of the scFv's were analyzed after radiolabeling.

10 and noncollagenous proteins was measured by radiolabeling.

11 phorylation sites of ICP27 following in vivo radiolabeling.

12 te and error associated with traditional 32P radiolabeling.

13 simplified design for single-step kit-based radiolabeling.

14 hydrazino-nicotinamide (S-HYNIC) followed by radiolabeling.

15 enetriaminepentaacetic acid to allow (111)In radiolabeling.

16 ng site-specific conjugation of chelates for radiolabeling.

17 TE, which was stored in 50-nmol aliquots for radiolabeling.

18 te/HCl (pH 4.5) solution suitable for direct radiolabeling.

19 acyclononane-1,4,7-triacetic acid for (64)Cu radiolabeling.

20 ared to be due to the use of a procedure for radiolabeling (111)In-ibritumomab tiuxetan that differed

21 ial agents for mapping human SERT by PET and radiolabeling 37 with iodine-123, which could afford the

22 n types I and V, determined by (14)C-proline radiolabeling; (4) by pepsin digestion and analysis of c

23 modified with desferoxamine for zirconium-89 radiolabeling ((89)Zr-DNP) and a near-infrared fluorochr

24 Here we present two methods for radiolabeling adeno-associated virus (AAV), one of the m

25 In vivo pulse radiolabeling analyses in retinal ganglion cell neurons

26 ction method together with mass spectral and radiolabeling analyses, we established that l-SMM is a m

27 Radiolabeling analysis of cultured COS-7 cells overexpre

28 Using in vitro radiolabeling and a rapid quenched-flow apparatus, we ex

29 ion by the modified probe was assessed using radiolabeling and a standard chronocoulometry method; bo

30 We conclude that performing the radiolabeling and CAFE assays in parallel is currently t

31 rands that were independently detected using radiolabeling and chronocoulometry.

32 Metabolic radiolabeling and epifluorescence microscopy of Jurkat l

33 on and purification of recombinant proteins, radiolabeling and evaluation in vivo.

34 Here, we report our methodology for radiolabeling and imaging monodisperse pharmacologic aer

35 We have previously reported on the radiolabeling and in vitro binding properties of monoclo

36 After conjugation with DOTA for (64)Cu radiolabeling and IRDye 800CW as a fluorophore, dual-lab

37 Radiolabeling and isotope dilution studies now confirm t

38 atalysis, we conducted a series of catalytic radiolabeling and kinetic experiments on the C-terminal

39 chondroitin sulfate determined by (35)SO(4) radiolabeling and measuring the sensitivity to endo-beta

40 Radiolabeling and microPET brain imaging studies were pe

41 affinity for integrin alphavbeta6, for (18)F radiolabeling and PET imaging of BxPC3 pancreatic adenoc

42 ors through conjugation with DOTA for (64)Cu radiolabeling and PET.

43 nd purification requires about 2-3 h and the radiolabeling and postlabeling purification requires abo

44 develop a simple, remote, "1-pot" method of radiolabeling and purification for the scaled-up radioio

45 BO translation was monitored by pulse-chase radiolabeling and rapid derivatization with a membrane-i

46 The precursor for radiolabeling and reference compounds was synthesized in

47 onsidered to have non-obvious strategies for radiolabeling and require a more customized approach.

48 DNA cleavage which replaces the traditional radiolabeling and scintillation counting with fluorescen

49 Using both radiolabeling and sensitive bioanalytical methods, we de

50 ously developed solution-phase (18)F-"click" radiolabeling and solid-phase radiolabeling using 4-[(18

51 g of one polymer construct was determined by radiolabeling and subcellular fractionation.

52 ated to maleimide-desferrioxamine for (89)Zr radiolabeling and subsequent small-animal PET/CT acquisi

53 tions that does not require a chromophore or radiolabeling and thus provides a viable alternative to

54 Previous radiolabeling and two-dimensional (2-D) gel studies of t

55 rescence, western blot analysis, pulse-chase radiolabeling, and biochemical subcellular fractionation

56 This study reports the synthesis, [(123)I]radiolabeling, and biological profile of a new series of

57 atorial chemistry, site-specific solid-phase radiolabeling, and in vivo imaging for the rapid screeni

58 On the basis of site-directed mutagenesis, radiolabeling, and kinetics experiments carried out with

59 o-immunoprecipitation, [(32)P]orthophosphate radiolabeling, and measurement of lipolysis.

60 , monitored wax biosynthesis through [(14)C]-radiolabeling, and sequenced the transcriptome.

61 njugation, providing a promising alternative radiolabeling approach that maintains the native in vivo

62 Here we compare the three different radiolabeling approaches and report the effects on PET i

63 ver, we employed shRNA library screening and radiolabeling approaches, as well as in vitro and in viv

64 Protein radiolabeling assays showed that, although individual th

65 -N'-ethylcarbodiimide with subsequent (64)Cu radiolabeling at 37 degrees C for 30 min.

66 labeling with thin layer chromatography and radiolabeling by glycosylation.

67 After radiolabeling, cell viability was unchanged.

68 nt imaging properties but greatly simplified radiolabeling compared with other (68)Ga-PSMA conjugates

69 Optimization of [(18)F]radiolabeling conditions and subsequent stability analys

70 Optimal radiolabeling conditions were identified and used in eig

71 cted cells was manipulated immediately after radiolabeling de novo-synthesized bacterial proteins.

72 After radiolabeling, each peptide was administered intravenous

73 5 degrees C for 2h) of (52)Mn gave excellent radiolabeling efficiencies of 97-100% and 98-100% respec

74 Radiolabeling efficiencies ranged from 33% to 88%, and i

75 exhibited exceptional cell transfection and radiolabeling efficiencies, providing an overall advanta

76 The radiolabeling efficiency (median +/- SD) of CHX-A-DTPA-H

77 The described novel protocol improves the radiolabeling efficiency and efficacy of DOTATOC, provid

78 Radiolabeling efficiency of the CHX-A-DTPA-HuM195 constr

79 The radiolabeling efficiency was 80%-85%, radiochemical puri

80 Two control radiolabelings, either with unreduced hMN-14 or with IMP

81 of the techniques, the different methods of radiolabeling erythrocytes, the procedure, useful indica

82 Finally, a preliminary radiolabeling essay has proven the facile [(18)F]-fluori

83 Metabolic radiolabeling experiments demonstrated that high level e

84 Radiolabeling experiments further demonstrated MltG-depe

85 On the contrary, radiolabeling experiments revealed impaired synthesis of

86 Radiolabeling experiments revealed that low molecular ma

87 pared from a wzxE-null mutant, and metabolic radiolabeling experiments revealed the accumulation of l

88 Radiolabeling experiments using [(3)H]palmitic acid or [

89 conditions were identified and used in eight radiolabeling experiments with 2IT-BAD-Lym-1 and a secon

90 (55)Fe-radiolabeling experiments with human cells depleted of C

91 In further radiolabeling experiments, 1-acyl-lyso-PC was predominan

92 a combination of kinetic studies, selective radiolabeling experiments, and cell viability assays to

93 Using radiolabeling experiments, we show that this carbide ori

94 Using co-immunoprecipitation and (55)Fe-radiolabeling experiments, we therefore studied the role

95 ected cells and biochemically by pulse-chase radiolabeling experiments.

96 c relationship was confirmed through various radiolabeling experiments.

97 ) using clotting assays, immunoblotting, and radiolabeling experiments.

98 for quantitative metabolite profiling, i.e., radiolabeling followed by high-performance liquid chroma

99 this laboratory and elsewhere, the method of radiolabeling had an important effect on the biodistribu

100 nnocuous, appending nanoparticles with these radiolabeling handles can have dramatic effects on impor

101 Heat-induced radiolabeling (HIR) yielded (89) Zr-Feraheme (FH) nanopa

102 Radiolabeling identified sn-2 monoacylglycerol as an ini

103 Therefore, radiolabeling in a centralized facility has numerous adv

104 The position of radiolabeling in the 3-N-methyl group was confirmed by [

105 ility has numerous advantages over localized radiolabeling in the preparation of 131I-labeled antibod

106 ter conjugation to a DFO chelator and (89)Zr radiolabeling, in assays including cell uptake, internal

107 Radiolabeling, including purification, was performed in

108 Sensitivity comparable to radiolabeling is achieved using oligonucleotide primers

109 Efficient radiolabeling is directly performed with aqueous [(18)F]

110 Using pulse-chase radiolabeling, it was determined that the portal protein

111 tapa-trastuzumab conjugates displayed faster radiolabeling kinetics with more reproducible yields und

112 We report optimized protocols for radiolabeling liposomes with (52)Mn, through both remote

113 ations, including insensitivity, reliance on radiolabeling, low throughput and an inability to resolv

114 here an improved MAG3 conjugation and 99mTc radiolabeling method capable of generating high radioche

115 We have characterized an efficient, 1-step radiolabeling method that produces stable, therapeutical

116 high yield, high specific activity, one-step radiolabeling method, high selectivity and favorable kin

117 We present a novel solid-phase based (45)Ti radiolabeling methodology and the implementation of (45)

118 The (18)F-radiolabeling methodology shown here is a robust procedu

119 generated a range of innovative chelate-free radiolabeling methods that exploit intrinsic chemical fe

120 greement with published values determined by radiolabeling methods.

121 After radiolabeling, microsomes were immunoisolated from trans

122 tween Hint1 and LysRS, a series of catalytic radiolabeling, mutagenesis, and kinetic experiments was

123 Similar yields were obtained in a subset of radiolabelings (n = 7) with >3.7 GBq of (131)I.

124 Classic methods for radiolabeling nanoparticles involve functionalization of

125 ry of 9 mechanistically distinct methods for radiolabeling nanoparticles is presented.

126 A central challenge in radiolabeling nanoparticles is to identify alternative c

127 e, 1-step, room-temperature syringe-and-vial radiolabeling of (68)Ga radiopharmaceuticals.

128 Radiolabeling of 5-HT7R selective compounds was performe

129 n, and SDS gel analysis revealed 2-fold more radiolabeling of 55-58-kDa 2B15-His by PKCalpha than by

130 Radiolabeling of 7 with no carrier added (18)F-radioisot

131 nation at RT was successfully applied to the radiolabeling of [(18)F]-2-fluoroethylamines in which th

132 , leading to a regiospecific reaction in the radiolabeling of [(18)F]-fluorodeprenyl.

133 Radiolabeling of a DOTA-folate conjugate (cm09) was perf

134 14C]palmitoyl CoA (5 microM) resulted in the radiolabeling of an 80 kDa band demonstrated by SDS-PAGE

135 Radiolabeling of antibodies and antibody fragments facil

136 20.3 min) possesses the unique potential for radiolabeling of any biological, naturally occurring, or

137 Our method does not require radiolabeling of any components and therefore can be use

138 The phosite reagent enables the enzymatic radiolabeling of any protein, peptide, or small molecule

139 ortant and versatile building blocks for the radiolabeling of biomolecules via Huisgen cycloaddition

140 allele (as1 allele) results in the exclusive radiolabeling of bona fide substrates of the mutant kina

141 The conjugation and radiolabeling of bovine serum albumin is used as an exam

142 (111)In radiolabeling of DOTA and (64)Cu radiolabeling of CB-TE2A conjugates yielded 370-1,850 an

143 eous sodium chloride (NaCl)-based method for radiolabeling of chelator-modified peptides for molecula

144 The radiolabeling of cm09 was achieved in a greater than 96%

145 Radiolabeling of cm09 was achieved with a radiochemical

146 otein kinases and [gamma-32P]ATP resulted in radiolabeling of CPT-I only by CKII.

147 (111)In radiolabeling of DOTA and (64)Cu radiolabeling of CB-TE2

148 n method of (44)Sc at a quality suitable for radiolabeling of DOTA-functionalized biomolecules.

149 ification of the ischemic state via targeted radiolabeling of hypoxia-induced angiogenic receptors is

150 Radiolabeling of IL2 with a positron-emitting isotope co

151 Radiolabeling of intact Sf9 cells expressing iPLA2beta w

152 Radiolabeling of monoclonal antibodies (mAbs) with an in

153 Radiolabeling of MSB0010853 with (89)Zr was performed wi

154 Radiolabeling of MSBP from 3H-mevalonate was confirmed b

155 ibroblasts from a human patient, pulse-chase radiolabeling of newly synthesized proteins is used to d

156 Radiolabeling of NOTA-AE105 with (64)Cu and (68)Ga was s

157 de as verified by both mass spectroscopy and radiolabeling of OPBM.

158 eloped in this study will also be useful for radiolabeling of other thiolated biomolecules.

159 lation of cellular CDP-choline, and enhanced radiolabeling of phosphatidylcholine.

160 Selective in vivo radiolabeling of plasma NTBI with (59)Fe revealed simila

161 Direct radiolabeling of proteins can result in the loss of targ

162 s the first that enables site-specific (11)C-radiolabeling of proteins.

163 By in vivo radiolabeling of rat DRGs, coupled to mass spectrometry

164 Radiolabeling of recombinant human cPLA(2)gamma with [(3

165 Radiolabeling of RS7-DOTA conjugate with (177)Lu-acetate

166 development of these modalities through the radiolabeling of somatostatin analogs with various radio

167 In addition, [(3)H]inositol radiolabeling of sterol biosynthesis inhibitor-treated w

168 Photoaffinity labeling studies show radiolabeling of subunits c and e.

169 [(18)F]Radiolabeling of sulfonyl chlorides in the presence of c

170 The TF-targeted tracer was developed through radiolabeling of the anti-human TF monoclonal antibody (

171 Radiolabeling of the DOTA-rhenium-cyclized peptides with

172 Following radiolabeling of the fatty-acylated proteins at Lys-15,

173 difficult using conventional methods such as radiolabeling of the oligonucleotide or fluorescence con

174 Radiolabeling of the prostate-specific membrane antigen

175 Radiolabeling of this protein was dependent on irradiati

176 hy (PET) that is being increasingly used for radiolabeling of tumor-targeting peptides.

177 Radiolabeling of VUF11211 gave [(3)H]VUF11211, which in

178 parameters has historically required direct radiolabeling or competition with a labeled tracer.

179 ncountered with previous strategies based on radiolabeling or fluorescence timer proteins, allowed us

180 Radiolabelings performed with freshly prepared solutions

181 recurrent prostate cancer by the use of one radiolabeling precursor, which can be radiolabeled eithe

182 c strategy that affords modular synthesis of radiolabeling precursors via a copper-catalyzed 'click'

183 was employed in efficiently synthesizing the radiolabeling precursors.

184 The high specific activity one-step radiolabeling preparation and high selectivity of [(123)

185 The high specific activity one-step radiolabeling preparation and high specificity and selec

186 Step 1A of this protocol describes a (64)Cu-radiolabeling procedure for 1,4,8,11-tetraazacyclododeca

187 Step 1B of this protocol describes the radiolabeling procedure for 4,11-bis(carboxymethyl)-1,4,

188 The radiolabeling procedure gave > or =95% radiometal incorp

189 the products, and the lack of cost-effective radiolabeling procedures.

190 h impactor stage for all 3 aerosols, and the radiolabeling process itself did not affect their partic

191 ed autophagic flux by two different methods (radiolabeling proteins and a dual-colored LC3 plasmid);

192 We used a radiolabeling protocol to quantify the relative amounts

193 time frame (1-4 h) well within that of most radiolabeling protocols, whereas fluorescence analyses u

194 gradation rates were determined using (35) S radiolabeling pulse chase.

195 Radiolabeling pulse/chase analysis demonstrated that E2F

196 DC018) equipped with both a DOTA chelate for radiolabeling purposes and a fluorophore (IRdye800CW) to

197 cal metal ion chelators that can be used for radiolabeling reactions have residualizing properties in

198 ers, but irrespective of the particle class, radiolabeling remains a key step.

199 Radiolabeling required 35 +/- 5 (mean +/- SD) min starti

200 charged nucleic acids (siRNA) and to undergo radiolabeling, respectively, for potential theranostic a

201 Radiolabeling revealed that mtDNA synthesis began soon a

202 Pulse-chase radiolabeling reveals that a ypk1Delta mutant exhibits i

203 ire process of conjugation, purification and radiolabeling should take approximately 12.5 h.

204 (35)S-radiolabeling showed that MotA and MotB are present in a

205 The new methodology does not require radiolabeling, so it remarkably widens the range of poss

206 of this study was to assess different (18)F radiolabeling strategies of the HER2-specific Affibody m

207 for the coupling of maleimide linkers, and 3 radiolabeling strategies were assessed: silicon-fluoride

208 Three radiolabeling strategies were evaluated to synthesize th

209 radiolabel molecules, and select a preferred radiolabeling strategy to progress for automated manufac

210 [(3)H]Dihydrosphingosine radiolabeling studies demonstrated that erg26-1 cells ha

211 [(3)H]inositol and [(3)H]dihydrosphingosine radiolabeling studies demonstrated that mutant cells had

212 Neutral lipid radiolabeling studies indicated that the rate of biosynt

213 [14C]palmitate radiolabeling studies of a GlpQ-alkaline phosphatase fus

214 In vivo radiolabeling studies reported here showed that male I.

215 Radiolabeling studies reveal that N(omega)-methoxy-L-arg

216 Phospholipid radiolabeling studies showed defects in the rate of bios

217 Phospholipid radiolabeling studies showed that arv1Delta cells harbor

218 Neutral lipid radiolabeling studies showed that erg26-1 cells also har

219 Radiolabeling studies showed that macropa, at submicromo

220 Radiolabeling studies support the existence of a nonsubs

221 opulations and, taken together with previous radiolabeling studies, provide strong evidence of in viv

222 Using [(3)H]inositol radiolabeling studies, we found that the biosynthetic ra

223 a1p, the yeast G alpha subunit, in metabolic radiolabeling studies.

224 ncluding the precursor preparation and (18)F radiolabeling, takes 7-10 d.

225 A new radiolabeling technique has recently been described that

226 Using pulse-chase radiolabeling techniques, we find that newly synthesized

227 the help of sophisticated bioconjugation or radiolabeling techniques.

228 nts without using expensive spectroscopic or radiolabeling techniques.

229 B0010853 biodistribution and tumor uptake by radiolabeling the Nanobody construct with (89)Zr.

230 By radiolabeling the tag sequence using Protein Kinase A, w

231 After radiolabeling, the phage was tested for binding at 1, 5,

232 ared with their stored test PAS platelets by radiolabeling their stored and control platelets with ei

233 Development of a method for radiolabeling these PC analogues, via hydrogenation of a

234 In addition, after radiolabeling, this monoclonal identified the site of en

235 Using either mass spectrometry or radiolabeling, this reagent may be used to reveal sites

236 The study observations suggest that radiolabeling through a (99m)Tc-dextran moiety may impro

237 Currently, radiolabeling through macrocyclic chelators is the most

238 ction, which significantly increases overall radiolabeling time and causes radioactivity loss.

239 ermine proteoglycan degradation, zymography, radiolabeling to determine chondrocyte biosynthesis, and

240 Radiolabeling to produce (18)F-SO3F(-) was simple and af

241 (18)F-"click" radiolabeling and solid-phase radiolabeling using 4-[(18)F]fluorobenzoic and 2-[(18)F]

242 Both in vivo radiolabeling (using [(32)P]orthophosphate) followed by

243 nsity in whole blood and after isolation and radiolabeling was 25.98 +/- 7.59 and 51.82 +/- 17.44, re

244 ld-type (wt) RFC was labeled; for K411A RFC, radiolabeling was abolished.

245 Radiolabeling was accomplished by a nucleophilic substit

246 Radiolabeling was accomplished with high radiochemical y

247 Radiolabeling was achieved by methylation of ethyl 6-bro

248 Radiolabeling was achieved via standard electrophilic io

249 Radiolabeling was complete (>95%) within 5 min at room t

250 In U937 cell membranes, the 47 kDa radiolabeling was inhibited in a concentration-dependent

251 ectrospray ionization-mass spectrometry, and radiolabeling was monitored by instant thin-layer chroma

252 Radiolabeling was not detected in membranes from HEK293T

253 In contrast, radiolabeling was not inhibited by 8,9-dihydroxyeicosatr

254 Radiolabeling was performed by pumping (89)Zr-oxalate an

255 (18)F radiolabeling was performed by reacting the tosylate pre

256 Radiolabeling was quantitative (>97%) after 5 min of inc

257 To study PIP(2) levels of cells without radiolabeling, we have developed a new method to quantif

258 Using fluorescence labeling and radiolabeling, we show that cholesterol modification ena

259 Enantiopure tosylate precursors for radiolabeling were obtained using chiral preparative hig

260 s exhibited DNA fragmentation in response to radiolabeling whereas only the p53(+/+) cells exhibited

261 nt in the solution phase, and its subsequent radiolabeling with (111)In (T(1/2) = 2.8 d) and (86)Y (T

262 -007 was successfully conjugated to DTPA for radiolabeling with (111)In at room temperature.

263 etriaminepentaacetic acid for the purpose of radiolabeling with (111)In.

264 ic acid (DOTA) conjugate of RS7 was used for radiolabeling with (177)Lu-acetate or (88/90)Y-acetate.

265 Radiolabeling with (18)F was based on the complexation o

266 rolled conjugation and polymerization before radiolabeling with (64)Cu for PET imaging in an apolipop

267 Radiolabeling with (64)Cu resulted in >95% of the (64)Cu

268 e-1,4,7-triacetic acid at the N terminus for radiolabeling with (64)Cu with a polyethylene glycol spa

269 C-terminal amino acids of bombesin(7-14) for radiolabeling with (64)Cu.

270 lator p-SCN-Bn-DFO was conjugated to AMG102, radiolabeling with (89)Zr was performed in high radioche

271 ted to the HER2 mAb trastuzumab, followed by radiolabeling with (89)Zr.

272 DFO-p-benzyl-isothiocyanate (DFO-Bz-NCS) for radiolabeling with (89)Zr.

273 onjugated to bifunctional chelator HYNIC for radiolabeling with (99m)Tc.

274 de-mercaptoacetyltriglycine (MAG3) to permit radiolabeling with (99m)Tc.

275 d contains a tyrosine residue, which enables radiolabeling with 125I.

276 ane (CB-TE2A) was conjugated to c(RGDyK) for radiolabeling with 64Cu (t(1/2), 12.7 h; beta+, 17.4%; E

277 Further optimization entailed radiolabeling with 99mTc and biodistribution in an AR42J

278 nctionalized biomolecules for the purpose of radiolabeling with 99mTc for gamma detection or single p

279 dnones was further highlighted by successful radiolabeling with [(18) F]Selectfluor.

280 t protein liquid chromatography (FPLC) after radiolabeling with [(3)H]-free cholesterol (FC).

281 e human Kv1.1 protein in Sf9 cells, covalent radiolabeling with [(3)H]palmitate, chemical stability s

282 on of selective Triton X-114 solubilization, radiolabeling with [(3)H]palmitic acid, and sucrose dens

283 n elegant new technique for combining iodine radiolabeling with an azamacrocyclic chelator to confer

284 Radiolabeling with fluorine-18 ((18)F) facilitated produ

285 4-FEPB, 8, K(i) = 1.83 nM) were selected for radiolabeling with fluorine-18.

286 modifications of oligonucleotides to permit radiolabeling with gamma- or positron emitters interfere

287 Radiolabeling with high specific activity [(11)C]methyl

288 Radiolabeling with I-124 was completed using a modified

289 ist 17 (DPC11870-11) is a DTPA conjugate for radiolabeling with In-111.

290 Radiolabeling with long-lived positron emission tomograp

291 esent in an ionic environment, was mapped by radiolabeling with N-[3H]ethylmaleimide and identified a

292 After radiolabeling with positron-emitting carbon-11, [(11)C]C

293 Radiolabeling with technetium-99m in aqueous media was e

294 This series includes hydrophilic ligands for radiolabeling with the [(99m)Tc(CO)3](+) core (L8-L10),

295 ugated to desferrioxamine (DFO) was used for radiolabeling with the PET isotopes 68Ga and 89Zr.

296 pembrolizumab in vivo, accomplished through radiolabeling with the positron emitter (89)Zr.

297 ange reaction, a method that is adaptable to radiolabeling with the positron-emitting isotope fluorin

298 cursors and methods are readily adaptable to radiolabeling with various radiohalides suitable for SPE

299 In 18 radiolabelings with (131)I in the range of 2.04-4.81 GBq

300 -methoxyphenyl)iodonium salt and its [(18)F] radiolabeling within a one-step, fully automated and cGM

301 F(121) was achieved in 90 +/- 10 min and the radiolabeling yield was 87.4% +/- 3.2%.